Profiling the epithelial‐mesenchymal transition‐related molecular markers demonstrated decreased CDH1, TJP1, and OCLN and increased ZEB1, FN1, and EZH2 in response to CDKN2A silencing in lung cancer cells. Here, CDKN2A is linked to lung cancer.